MARKER THERAPEUTICS, INC. Current Assets
MARKER THERAPEUTICS, INC. (MRKR) had Current Assets of $14.59 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $14.59M.
- 2026-03-31: Assets, Current $17.43M.
- 2025-12-31: Assets, Current $19.07M.
- 2025-09-30: Assets, Current $21.73M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.59M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $17.43M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $19.07M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $21.73M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $14.77M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $16.99M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $22.02M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $10.91M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $11.68M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $14.09M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $17.13M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $19.49M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $21.96M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $10.91M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $16.62M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $22.42M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $29.28M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $31.02M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $45.98M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $51.41M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $60.02M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $67.47M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $24.41M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $30.32M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $34.76M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $42.00M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $45.49M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $50.46M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $54.03M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $58.04M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $62.00M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $4.39M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $7.89M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.93M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $5.18M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $7.70M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.14M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $6.11M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $7.92M 10-K · filed 2018-03-23 | |
| 2016-06-30 | $3.79M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $5.76M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $6.65M 10-Q · filed 2016-08-15 | |
| 2015-09-30 | $6.23M 10-Q/A · filed 2016-04-14 | |
| 2015-06-30 | $3.25M 10-Q/A · filed 2016-04-14 | |
| 2014-12-31 | $224.45K 10-Q/A · filed 2016-04-14 | |
| 2014-09-30 | $643.65K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $35.65K 10-Q · filed 2014-08-18 | |
| 2013-12-31 | $77.03K 10-K · filed 2015-04-15 | |
| 2013-03-31 | $151.36K 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | $87.37K 10-Q/A · filed 2013-08-19 | $104.21K 10-K · filed 2013-05-15 |
| 2012-09-30 | $39.97K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $39.54K 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $66.31K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $340.21K 10-K · filed 2013-05-15 | $307.92K 10-K · filed 2012-04-16 |
| 2011-09-30 | $60.91K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $52.01K 10-Q · filed 2011-08-22 | |
| 2010-12-31 | $25.30K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |